Opportunity
Simpler Grants.gov #HT942526TBDRPTDRA
Tick-Borne Disease Therapeutic/Diagnostic Research Grant Solicitation
Buyer
U.S. Army Medical Research Acquisition Activity
Posted
October 04, 2023
Identifier
HT942526TBDRPTDRA
NAICS
541715, 541714
This opportunity from the Department of the Army (USAMRAA) supports research and development for therapeutics and diagnostics targeting tick-borne diseases. - Government Buyer: - Department of the Army - US Army Medical Research Acquisition Activity (USAMRAA) - Products/Services Requested: - Product-driven research for therapeutic evaluation and diagnostic development - Focus on early/preclinical drug or treatment discovery - Diagnostic approaches suitable for clinical integration - OEMs and Vendors: - No specific OEMs or vendors are named; this is a research grant - Unique/Notable Requirements: - No cost sharing or matching requirement - Funding instrument is a discretionary grant - Emphasis on reducing the burden of Lyme disease and other tick-borne diseases - Goal to improve patient care and quality of life - Place of Performance: - US Army Medical Research Acquisition Activity (USAMRAA)
Description
The fiscal year 2026 Tick-Borne Disease Research Program Therapeutic/Diagnostic Research Award aims to support product-driven therapeutic and diagnostic development research to reduce the burden of Lyme disease and other tick-borne diseases, improving patient care and quality of life. Treatment-focused applications should be early/preclinical therapeutic evaluation studies for drug or treatment discovery. Diagnosis-focused applications should propose diagnostic approaches suitable for clinical integration. The award is a grant with no cost sharing or matching requirement and is discretionary funding for science, technology, and research development.